TC-C 14GPotent, high affinity CB1 receptor inverse agonist CAS# 656804-72-7 |
- Nadifloxacin
Catalog No.:BCC4804
CAS No.:124858-35-1
- Calcipotriol monohydrate
Catalog No.:BCC1445
CAS No.:147657-22-5
- Halobetasol Propionate
Catalog No.:BCC4664
CAS No.:66852-54-8
- Dihydroartemisinin
Catalog No.:BCN6264
CAS No.:71939-50-9
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 656804-72-7 | SDF | Download SDF |
PubChem ID | 22475020 | Appearance | Powder |
Formula | C24H17Cl2F2NO4 | M.Wt | 492.3 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble to 100 mM in DMSO and to 100 mM in ethanol | ||
Chemical Name | [2-(2,4-dichlorophenyl)-6-fluoro-2-(4-fluorophenyl)-1,3-benzodioxol-5-yl]-morpholin-4-ylmethanone | ||
SMILES | C1COCCN1C(=O)C2=CC3=C(C=C2F)OC(O3)(C4=CC=C(C=C4)F)C5=C(C=C(C=C5)Cl)Cl | ||
Standard InChIKey | VUCKSZWMRCSPME-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C24H17Cl2F2NO4/c25-15-3-6-18(19(26)11-15)24(14-1-4-16(27)5-2-14)32-21-12-17(20(28)13-22(21)33-24)23(30)29-7-9-31-10-8-29/h1-6,11-13H,7-10H2 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Potent, high affinity CB1 receptor inverse agonist (EC50 = 11 nM in cAMP assay; Ki = 4 nM). Demonstrates high efficacy in a hypothermia assay (ID50 = 5 mg/kg) in vivo. |
TC-C 14G Dilution Calculator
TC-C 14G Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.0313 mL | 10.1564 mL | 20.3128 mL | 40.6256 mL | 50.782 mL |
5 mM | 0.4063 mL | 2.0313 mL | 4.0626 mL | 8.1251 mL | 10.1564 mL |
10 mM | 0.2031 mL | 1.0156 mL | 2.0313 mL | 4.0626 mL | 5.0782 mL |
50 mM | 0.0406 mL | 0.2031 mL | 0.4063 mL | 0.8125 mL | 1.0156 mL |
100 mM | 0.0203 mL | 0.1016 mL | 0.2031 mL | 0.4063 mL | 0.5078 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- AG-1024
Catalog No.:BCC1242
CAS No.:65678-07-1
- HA14-1
Catalog No.:BCC3593
CAS No.:65673-63-4
- Silybin B maltoside
Catalog No.:BCC8250
CAS No.:335299-49-5
- Esculentoside E
Catalog No.:BCN5014
CAS No.:65649-36-7
- Fenretinide
Catalog No.:BCC1572
CAS No.:65646-68-6
- Nintedanib (BIBF 1120)
Catalog No.:BCC3661
CAS No.:656247-17-5
- Ophiopogonin D'
Catalog No.:BCN2645
CAS No.:65604-80-0
- Cerberic acid
Catalog No.:BCN4200
CAS No.:65597-44-6
- Cerbinal
Catalog No.:BCN4199
CAS No.:65597-42-4
- 4'-Demethylepipodophyllotoxin
Catalog No.:BCN5918
CAS No.:6559-91-7
- 1-Hydroxyacridone
Catalog No.:BCN7524
CAS No.:65582-54-9
- Europine N-oxide
Catalog No.:BCN1977
CAS No.:65582-53-8
- Reversine
Catalog No.:BCC1892
CAS No.:656820-32-5
- Metformin
Catalog No.:BCC9026
CAS No.:657-24-9
- H-Lys-OH.2HCl
Catalog No.:BCC2979
CAS No.:657-26-1
- H-Lys-OH.HCl
Catalog No.:BCC2978
CAS No.:657-27-2
- Z-D-Glu-OBzl
Catalog No.:BCC2774
CAS No.:65706-99-2
- Apramycin Sulfate
Catalog No.:BCC4628
CAS No.:65710-07-8
- Boc-Dap(Z)-OH.DCHA
Catalog No.:BCC2667
CAS No.:65710-58-9
- Z-D-Ser(tBu)-OH
Catalog No.:BCC2739
CAS No.:65806-90-8
- 3-Eudesmene-1beta,11-diol
Catalog No.:BCN7096
CAS No.:658062-22-7
- 10(14)-Cadinene-4,11-diol
Catalog No.:BCN7099
CAS No.:658062-23-8
- Goserelin Acetate
Catalog No.:BCC5352
CAS No.:65807-02-5
- SU11274
Catalog No.:BCC1243
CAS No.:658084-23-2
Benzodioxoles: novel cannabinoid-1 receptor inverse agonists for the treatment of obesity.[Pubmed:18335976]
J Med Chem. 2008 Apr 10;51(7):2115-27.
The application of the evolutionary fragment-based de novo design tool TOPology Assigning System (TOPAS), starting from a known CB1R (CB-1 receptor) ligand, followed by further refinement principles, including pharmacophore compliance, chemical tractability, and drug likeness, allowed the identification of benzodioxoles as a novel CB1R inverse agonist series. Extensive multidimensional optimization was rewarded by the identification of promising lead compounds, showing in vivo activity. These compounds reversed the CP-55940-induced hypothermia in Naval Medical Research Institute (NMRI) mice and reduced body-weight gain, as well as fat mass, in diet-induced obese Sprague-Dawley rats. Herein, we disclose the tools and strategies that were employed for rapid hit identification, synthesis and generation of structure-activity relationships, ultimately leading to the identification of (+)-[( R)-2-(2,4-dichloride-phenyl)-6-fluoro-2-(4-fluoro-phenyl)-benzo[1,3]dioxol-5-yl]- morpholin-4-yl-methanone ( R)-14g . Biochemical, pharmacokinetic, and pharmacodynamic characteristics of ( R)-14g are discussed.